Zycov D-human-trials

Showing of 1 - 20 from 2 results
Zycov D-human-trials - Total results - 2
Zydus Cadila's COVID-19 vaccine passes Phase I safety trials; Phase II to test efficiency begins 6 August
India

Zydus Cadila's COVID-19 vaccine passes Phase I safety trials; Phase II to test efficiency begins 6 August

The vaccine candidate was found 'very safe' after volunteers in the Phase I trial were examined at 24 hours and 7 days after the shot.

Zydus Cadila begins human trials of COVID-19 vaccine candidate ZyCoV-D in 1,000 volunteers
India

Zydus Cadila begins human trials of COVID-19 vaccine candidate ZyCoV-D in 1,000 volunteers

Zydus is only the second Indian pharma firm to get DCGI's nod for human trials of its vaccine candidate.